Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 1681 | 1503 | 0.0254 | 0.0314 | 0.8941 | 0.8595 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 1135 | 1078 | 0.0081 | 0.0064 | 0.9498 | 0.9579 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 937 | 901 | 0.0051 | 0.0064 | 0.9616 | 0.9579 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 1090 | 1049 | 0.0059 | 0.0064 | 0.9624 | 0.9579 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 1440 | 1382 | 0.0083 | 0.0084 | 0.9597 | 0.9531 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 2 | 1275 | 1218 | 0.0081 | 0.0084 | 0.9553 | 0.9531 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 1093 | 1032 | 0.0087 | 0.0084 | 0.9442 | 0.9531 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 1247 | 1183 | 0.0091 | 0.0097 | 0.9487 | 0.9430 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 1231 | 1160 | 0.0101 | 0.0097 | 0.9423 | 0.9430 |
COLO 858 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 1115 | 1046 | 0.0099 | 0.0097 | 0.9381 | 0.9430 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 10128 | 1461 | 1.0290 | 1.0000 | 0.1443 | 0.1501 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 10083 | 1500 | 1.0190 | 1.0000 | 0.1488 | 0.1501 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 9513 | 1495 | 0.9520 | 1.0000 | 0.1572 | 0.1501 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 8772 | 1469 | 0.8671 | 0.8985 | 0.1675 | 0.1651 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 8670 | 1397 | 0.8635 | 0.8985 | 0.1611 | 0.1651 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 9755 | 1627 | 0.9650 | 0.8985 | 0.1668 | 0.1651 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 4700 | 704 | 0.4744 | 0.5301 | 0.1498 | 0.1528 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 5704 | 880 | 0.5727 | 0.5301 | 0.1543 | 0.1528 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 5409 | 834 | 0.5432 | 0.5301 | 0.1542 | 0.1528 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 1609 | 714 | 0.1063 | 0.1023 | 0.4438 | 0.4297 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 1666 | 709 | 0.1136 | 0.1023 | 0.4256 | 0.4297 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 1265 | 531 | 0.0871 | 0.1023 | 0.4198 | 0.4297 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 4152 | 336 | 0.4531 | 0.4516 | 0.0809 | 0.0851 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 4062 | 356 | 0.4400 | 0.4516 | 0.0876 | 0.0851 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 4258 | 369 | 0.4617 | 0.4516 | 0.0867 | 0.0851 |